A Non-Chromatographic Method for the Purification of a Bivalently Active Monoclonal IgG Antibody from Biological Fluids
Autor: | Lara A. Estroff, Basar Bilgicer, Bryan F. Shaw, George K. Kaufman, Vijay M. Krishnamurthy, Samuel W. Thomas, George M. Whitesides, Jerry Yang |
---|---|
Rok vydání: | 2009 |
Předmět: |
Models
Molecular Digoxin Ammonium sulfate Globulin medicine.drug_class chemical and pharmacologic phenomena Monoclonal antibody Biochemistry Article Catalysis Immunoglobulin G Monoclonal IgG Mice chemistry.chemical_compound Colloid and Surface Chemistry medicine Animals Chemical Precipitation Binding site Chromatography biology Chemistry Antibodies Monoclonal Ascites General Chemistry Rats Dinitrobenzenes Ammonium Sulfate Chromatography Gel biology.protein Binding Sites Antibody Antibody Dimerization Haptens Hapten |
Zdroj: | Journal of the American Chemical Society. 131:9361-9367 |
ISSN: | 1520-5126 0002-7863 |
DOI: | 10.1021/ja9023836 |
Popis: | This paper describes a method for the purification of monoclonal antibodies (rat anti-2,4-dinitrophenyl IgG: IgG(DNP); and mouse antidigoxin IgG: IgG(Dgn)) from ascites fluid. This procedure (for IgG(DNP)) has three steps: (i) precipitation of proteins heavier than immunoglobulins with ammonium sulfate; (ii) formation of cyclic complexes of IgG(DNP) by causing it to bind to synthetic multivalent haptens containing multiple DNP groups; (iii) selective precipitation of these dimers, trimers, and higher oligomers of the target antibody, followed by regeneration of the free antibody. This procedure separates the targeted antibody from a mixture of antibodies, as well as from other proteins and globulins in a biological fluid. This method is applicable to antibodies with a wide range of monovalent binding constants (0.1 microM to 0.1 nM). The multivalent ligands we used (derivatives of DNP and digoxin) isolated IgG(DNP) and IgG(Dgn) from ascites fluid in yields of >80% and with >95% purity. This technique has two advantages over conventional chromatographic methods for purifying antibodies: (i) it is selective for antibodies with two active Fab binding sites (both sites are required to form the cyclic complexes) over antibodies with one or zero active Fab binding sites; (ii) it does not require chromatographic separation. It has the disadvantage that the structure of the hapten must be compatible with the synthesis of bi- and/or trivalent analogues. |
Databáze: | OpenAIRE |
Externí odkaz: |